Evidence map›Paper›PMID 25316723›Full record

ArticleInvestigative ophthalmology & visual science2014

A missense mutation in HK1 leads to autosomal dominant retinitis pigmentosa.

Feng Wang, Yandong Wang, Bin Zhang, Li Zhao, Vera Lyubasyuk, Keqing Wang, Mingchu Xu, Yumei Li, Frances Wu, Cindy Wen and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Autosomal dominant pigmented paravenous retinochoroidal atrophy associated with pathogenic variant in HK1 gene.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. AnInternational journal of ophthalmology · 2026
    Article
  4. Article
  5. Autosomal dominantGenetics in medicine open · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Expanding the Molecular Spectrum ofArchives of Iranian medicine · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Feng WangHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Yandong WangZhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Bin ZhangHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Li ZhaoHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Structural and Computational Biology and Molecular Biophysics Graduate Program, Baylor College of Medicine, Houston, Texas, United States.
Vera LyubasyukShiley Eye Center and Institute for Genomic Medicine, University of California-San Diego, La Jolla, California, United States.
Keqing WangHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Mingchu XuHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Yumei LiHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Frances WuShiley Eye Center and Institute for Genomic Medicine, University of California-San Diego, La Jolla, California, United States.
Cindy WenShiley Eye Center and Institute for Genomic Medicine, University of California-San Diego, La Jolla, California, United States.
Paul S BernsteinDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City, Utah, United States.
Danni LinShiley Eye Center and Institute for Genomic Medicine, University of California-San Diego, La Jolla, California, United States.
Susanna ZhuShiley Eye Center and Institute for Genomic Medicine, University of California-San Diego, La Jolla, California, United States.
Hui WangHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States.
Kang ZhangShiley Eye Center and Institute for Genomic Medicine, University of California-San Diego, La Jolla, California, United States Veterans Administration Healthcare System, San Diego, California, United States.
Rui ChenHuman Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, United States Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States Structural and Computational Biology and Molecular Biophysics Graduate Program, Baylor College of Medicine, Houston, Texas, United States The Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States Program in Developmental Biology, Baylor College of Medicine, Houston, Texas, United States.
University of California, San Diego · USBaylor Genetics · USBaylor College of Medicine · USSun Yat-sen University · CNUniversity of Utah · US

Funding

Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, NEUL, JEFFREY L · 2014 to 2019
$7.8M
Molecular Basis of Human Visual System DisordersR01EY022356 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI RUI CHEN · 2012 to 2026
$6.1M
FGI: Acquisition of an Illumina Genome Analyzer System for Functional Genomic ResS10RR026550 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI · 2010 to 2010
$500k
NCRR NIH HHS 1S10RR026550NCRR NIH HHS S10 RR026550NEI NIH HHS R01 EY022356NEI NIH HHS R01EY022356NICHD NIH HHS U54 HD083092
6 · The paper itself

Abstract

purposeRetinitis pigmentosa (RP) is a genetically heterogeneous disease with over 60 causative genes known to date. Nevertheless, approximately 40% of RP cases remain genetically unsolved, suggesting that many novel disease-causing genes are yet to be identified. In this study, we aimed to identify the causative mutation for a large autosomal dominant RP (adRP) family with negative results from known retinal disease gene screening.

methodsLinkage analysis followed by whole-exome sequencing was performed. Stringent variant filtering and prioritization was carried out to identify the causative mutation.

resultsLinkage analysis identified a minimal disease region of 8 Mb on chromosome 10 with a peak parametric logarithm (base 10) of odds (LOD) score of 3.500. Further whole-exome sequencing identified a heterozygous missense mutation (NM_000188.2:c.2539G>A, p.E847K) in hexokinase 1 (HK1) that segregated with the disease phenotype in the family. Biochemical assays showed that the E847K mutation does not affect hexokinase enzymatic activity or the protein stability, suggesting that the mutation may impact other uncharacterized function or result in a gain of function of HK1.

conclusionsHere, we identified HK1 as a novel causative gene for adRP. This is the first report that associates the glucose metabolic pathway with human retinal degenerative disease, suggesting a potential new disease mechanism.

Indexed as

Genetic Predisposition to DiseaseMutation, MissenseAdolescentChildChild, PreschoolDNADNA Mutational AnalysisFemaleGenes, DominantGenetic LinkageHeterozygoteHexokinaseHumansMalePedigreePhenotypeDNAHexokinaseHK1 protein, humanautosomal dominant retinitis pigmentosa (adRP)hexokinaseHK1next-generation sequencing (NGS)novel disease-causing gene

Identifiers

PMID25316723
PMCPMC4224578
OpenAlexW2323119641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.